[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100636715":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":29,"locations":35,"responsibleParty":54,"collaborators":25,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":25,"eligibilityCriteria":62,"healthyVolunteers":58,"sex":63,"minAge":64,"maxAge":65,"enrollmentInfo":66,"targetDuration":25,"studyType":69,"phases":70,"briefSummary":72,"conditions":73,"keywords":75,"overallStatus":80,"whyStopped":25,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Bedaya Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Double trigger","EXPERIMENTAL","GnRH agonist is administered 38 - 39 hours prior to ovum pick-up and HCG is administered 35 - 36 hours prior to ovum pick-up, respectively.",[13],"Drug: Double trigger",{"label":15,"type":16,"description":17,"interventionNames":18},"HCG trigger","ACTIVE_COMPARATOR","HCG is administered 35 - 36 h prior to ovum pick-up",[19],"Drug: HCG trigger",[21,26],{"type":22,"name":9,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Triptorelin (0.2 mg\u002FS.C ) and HCG (10000 IU\u002FI.M) are administered 38 to 39 h and 35 to 36 h prior to ovum pick-up., respectively.",[9],null,{"type":22,"name":15,"description":27,"armGroupLabels":28,"otherNames":25},"HCG (10000 IU\u002FI.M) is administered 35 to 36 h prior to ovum pick-up.",[15],[30],{"name":31,"role":32,"phone":33,"phoneExt":25,"email":34},"Usama M Fouda, Prof.","CONTACT","+201095401375","umfrfouda@yahoo.com",[36],{"facility":5,"status":25,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Giza","Giza Governorate","3753303","Egypt","EG",{"type":43,"coordinates":44},"Point",[45,46],31.20861,30.00944,{"lat":46,"lon":45},[49,51],{"name":50,"role":32,"phone":33,"phoneExt":25,"email":34},"Usama M Fouda, Prof",{"name":52,"role":53,"phone":25,"phoneExt":25,"email":25},"Reham Elkhalifa, M.D, PhD","PRINCIPAL_INVESTIGATOR",{"type":55,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100636715","phase-2-triggering-oocyte-maturation-in-poseidon-group-3-and-4-poor-responders-using-double-trigger-or-hcg-trigger-100636715",false,"NCT07569289","Triggering Oocyte Maturation in POSEIDON Group 3 and 4 Poor Responders Using Double Trigger or HCG Trigger","Triggering Oocyte Maturation in POSEIDON Group 3 and 4 Poor Responders Using Double Trigger or HCG Trigger . A Randomized Controlled Study","Inclusion Criteria:\n\n* POSEIDON group 3 and 4\n* GnRH antagonist IVF cycle\n\nExclusion Criteria:\n\n* Hypogonadotrophic hypogonadism\n* Endometriosis\n* History of recurrent abortion","FEMALE","18 Years","40 Years",{"count":67,"type":68},164,"ESTIMATED","INTERVENTIONAL",[71],"PHASE2","The aim of this randomized controlled study is to compare the efficacy of double trigger protocol \\[ the co-administration of GnRH agonist with HCG ( 38 - 39 and 35 - 36 h prior to ovum pick-up, respectively \\] with HCG in triggering ovulation in patients with expected poor response to ovarian stimulation",[74],"Infertility",[74,76,77,78,79,9],"Poor responders","IVF-ET","HCG","GnRH agonist","NOT_YET_RECRUITING","2026-04-29",{"date":83,"type":84},"2026-05-06","ACTUAL",{"date":86,"type":68},"2026-06-01",{"date":88,"type":68},"2028-04-01",{"name":5,"class":6},1]